ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ReliefNow Laser Inland Empire Expands with Dr. Matthew Zerebny, Offering Gentle & Painless Pain Relief

ReliefNow® Laser Inland Empire, led by chiropractor Dr. Matthew Zerebny, is expanding to bring the proprietary “gentle & painless” Class IV Regenerative Medical Laser™ therapy to patients across Southern California. This breakthrough treatment helps reduce inflammation, swelling, and chronic pain while accelerating the body’s natural healing process.

Patients now have a safe, non-invasive option to avoid unnecessary surgery or long-term drug use.

“Too often, patients are told their only options are surgery or medication,” said Dr. Matthew Zerebny. “ReliefNow® gives us the ability to get to the root cause instead of masking symptoms. Our goal is to help patients return to an active, pain-free life without unnecessary drugs or invasive procedures.”

Bio-Stacking + ReliefNow®

At Zerebny Chiropractic Clinics, patients benefit from Dr. Zerebny’s advanced bio-stacking techniques, which combine natural and biohacking modalities to optimize physical, mental, and emotional health.

With six certifications beyond his Doctor of Chiropractic degree and a background in strength and conditioning, Dr. Zerebny designs personalized programs that help patients restore energy, mobility, and balance.

The addition of ReliefNow®’s Class IV Regenerative Medical Laser™ enhances this holistic approach by:
• Reducing inflammation and swelling at the cellular level
• Blocking pain signals and stimulating natural endorphins
• Accelerating tissue repair and recovery after injuries
• Supporting mobility and quality of life for chronic pain sufferers

Serving Patients Others Have Given Up On

Dr. Zerebny is passionate about helping patients who have been told, “there’s nothing else we can do.” By combining cutting-edge technology with compassionate, whole-body care, he restores hope and delivers measurable results for those seeking real, lasting solutions to chronic pain.

“I look forward to assisting you on your journey toward a life filled with higher levels of health and vitality,” added Dr. Zerebny.

About Dr. Matthew Zerebny

Before earning his Doctor of Chiropractic degree, Dr. Matthew Zerebny was a Strength and Conditioning Specialist with undergraduate training in Pre-Med at UCLA. His unique blend of scientific training, athletic performance insight, and holistic philosophy allows him to craft individualized programs for patients facing chronic pain, injury recovery, and complex health challenges.

About ReliefNow® Laser Pain Centers

ReliefNow® is transforming healthcare with its proprietary Regenerative Medical Laser™ protocol and innovative Un-Franchise model. ReliefNow® empowers providers to deliver non-invasive, drug-free care that enhances patient outcomes while generating new cash-based revenue streams.

ReliefNow® – Ditch the Drugs and Skip the Scalpel®.

ReliefNow® offers:
• Innovative, Evidence-Based Technology — Class IV Regenerative Medical Laser™, delivering deep-tissue healing with light energy.
• Clinical Benefits for Patients — Pain relief, inflammation reduction, faster recovery, improved mobility.
• Business Benefits for Providers — New six-figure cash-pay revenue potential, reduced insurance dependency, and renewed professional fulfillment.
• Scalable “Un-Franchise” Model — A turnkey, practice-within-a-practice system providing branding, marketing, and training without high franchise fees or restrictions.

Website: www.ReliefNowLaser.com/providers/inland-empire

Recent Quotes

View More
Symbol Price Change (%)
AMZN  221.90
+5.42 (2.50%)
AAPL  263.22
+0.98 (0.37%)
AMD  237.66
-2.90 (-1.21%)
BAC  51.96
-0.08 (-0.15%)
GOOG  246.68
-10.34 (-4.02%)
META  729.64
-2.53 (-0.35%)
MSFT  516.00
-0.79 (-0.15%)
NVDA  181.93
-0.71 (-0.39%)
ORCL  279.10
+1.92 (0.69%)
TSLA  446.47
-0.96 (-0.22%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.